| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 07/03/2003 | CA2470594A1 Leptin proteins |
| 07/03/2003 | CA2469644A1 Method for large scale production of virus antigen |
| 07/03/2003 | CA2469370A1 Adipose-derived cell processing unit |
| 07/03/2003 | CA2469263A1 Raf/ras binding compounds |
| 07/03/2003 | CA2468882A1 A library of modified structural genes or capsid modified particles useful for the identification of viral clones with desired cell tropism |
| 07/03/2003 | CA2468778A1 Isolation tool for viable c-kit expressing cells |
| 07/03/2003 | CA2468083A1 Use of heterocyclic carboxamides to treat anemia |
| 07/03/2003 | CA2467207A1 Novel phytases and method for producing these phytases |
| 07/03/2003 | CA2466885A1 Non-human primate fc receptors and methods of use |
| 07/03/2003 | CA2465283A1 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 07/03/2003 | CA2462670A1 Sperm-specific cation channel, catsper2, and uses therefor |
| 07/03/2003 | CA2462587A1 Modulating insulin receptor signaling through targeting facl |
| 07/03/2003 | CA2453810A1 Mutant proteinase inhibitors and uses thereof |
| 07/02/2003 | EP1324040A2 Direct selection of cells by secretion product |
| 07/02/2003 | EP1323826A1 A cell line expressing mutated human tissue - type plasminogen activator, the constructing strategy thereof and method of preparing expressed protein |
| 07/02/2003 | EP1323824A2 Use of human keratinocyte growth factor-2 for the preparation of pharmaceutical compositions |
| 07/02/2003 | EP1323821A1 Process for producing normal parenchymal cells, tissue or organ by bioincubator |
| 07/02/2003 | EP1323732A1 Beta-catenin nuclear localizing protein |
| 07/02/2003 | EP1323475A2 Microfluidic devices based on norbornene plastics and the like |
| 07/02/2003 | EP1323428A2 Avirulent Salmonella typhi microbes and uses thereof |
| 07/02/2003 | EP1322774A2 Gene delivery vectors provided with a tissue tropism for dendritic cells |
| 07/02/2003 | EP1322769A2 Protein phosphatases |
| 07/02/2003 | EP1322768A2 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 07/02/2003 | EP1322762A2 Haemophilus influenzae antigens and corresponding dna fragments |
| 07/02/2003 | EP1322761A1 A humanized antibody to surface antigen s of hepatitis b virus and a preparing method thereof |
| 07/02/2003 | EP1322760A2 G-protein coupled receptors |
| 07/02/2003 | EP1322759A2 Potassium channel interactors and uses therefor |
| 07/02/2003 | EP1322757A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 07/02/2003 | EP1322756A1 MANIPULATION OF PLANT SENESCENCE USING AN i MYB /i GENE PROMOTER AND CYTOKININ BIOSYNTHESIS GENES |
| 07/02/2003 | EP1322752A2 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof |
| 07/02/2003 | EP1322751A2 Glutaryl cephalosporin amidase from pseudomonas diminuta bs-203 |
| 07/02/2003 | EP1322749A1 Assay for rapid detection of human activated protein c and highly specific monoclonal antibody therefor |
| 07/02/2003 | EP1322748A2 Stem cell differentiation-inducing promoter |
| 07/02/2003 | EP1322546A1 Microscopic networks of containers and nanotubes |
| 07/02/2003 | EP1322287A2 Microparticles for delivery of the heterologous nucleic acids |
| 07/02/2003 | EP1292249A4 Tissue engineered stents |
| 07/02/2003 | EP1285057A4 Isolation of mesenchymal stem cells and use thereof |
| 07/02/2003 | EP1227825A4 Isolation and expansion of human marrow stromal cells |
| 07/02/2003 | EP1194035A4 Mammalian myeloid progenitor cell subsets |
| 07/02/2003 | EP1163103B1 Use of gas plasma hydrophilised surface as a liquid contact surface and microfabricated device containing a gas plasma hydrophilised surface |
| 07/02/2003 | EP1107662A4 Manipulation of tocopherol levels in transgenic plants |
| 07/02/2003 | EP1021523A4 Liver regeneration using pancreas cells |
| 07/02/2003 | EP0904353B1 Cell culture process and medium, cellular composition obtained and its application as production system and study model |
| 07/02/2003 | EP0879282B1 Immunotherapy using cytotoxic t lymphocytes (ctl) |
| 07/02/2003 | EP0877547A4 Plant glutamate receptors |
| 07/02/2003 | EP0826043B1 Methods for modulating t cell survival by modulating bcl-xl protein level |
| 07/02/2003 | EP0781343B1 Retroviral vector hybrids and the use thereof for gene transfer |
| 07/02/2003 | EP0732875B1 Methods of modifying feeding behavior, compounds useful in such methods, and dna encoding a hypothalamic atypical neuropeptide y/peptide yy receptor (y5) |
| 07/02/2003 | EP0731845B1 Homologous recombination antibody expression system for murine cells |
| 07/02/2003 | EP0616644B1 Fatty acid desaturase genes from plants |
| 07/02/2003 | CN1427892A Virulence genes, proteins and their use |
| 07/02/2003 | CN1427889A Hybrid cells obtainable from antigen presenting cells |
| 07/02/2003 | CN1427888A Method and apparatus for culturing cell or tissue |
| 07/02/2003 | CN1427887A Pluripotent cells comprising allogenic nucleus and mitochondria |
| 07/02/2003 | CN1427725A Casein derived peptides and uses thereof in therapy |
| 07/02/2003 | CN1113099C New carrier for gene treatment |
| 07/02/2003 | CN1113097C Processes for preparation of Marek's disease virus using continuous mammalian cell lines |
| 07/02/2003 | CN1113096C New stromal cell lines from human bone marrow and their use |
| 07/02/2003 | CN1113095C Process for packaging plant tissues cultured in vitro |
| 07/02/2003 | CN1112855C Process for stabilizing proteins in acidic environment with high-ester pectin |
| 07/01/2003 | USH2074 Fertile transgenic corn plants |
| 07/01/2003 | US6586661 Regulation of quinolate phosphoribosyl transferase expression by transformation with a tobacco quinolate phosphoribosyl transferase nucleic acid |
| 07/01/2003 | US6586656 Transgenic rodents harboring APP allele having Swedish mutation |
| 07/01/2003 | US6586571 Isolated polypeptide that binds to MORT-1 (mediators of receptor toxicity) protein |
| 07/01/2003 | US6586569 Endometriosis-associated gene |
| 07/01/2003 | US6586406 Method of inducing or enhancing chondrogenesis with extracellular matrix containing GDF-5 |
| 07/01/2003 | US6586397 Polypeptides encoding tyrosine kinase containing immunoglobulin and endithelial growth factor homology domains; induce vascularization |
| 07/01/2003 | US6586396 Subcutaneous administration of natriuretic peptide |
| 07/01/2003 | US6586395 Apoptosis-modulating proteins |
| 07/01/2003 | US6586392 Conjugates of antiviral proteins or peptides and virus or viral envelope glycoproteins |
| 07/01/2003 | US6586251 Genetically engineering cells; obtain cells, transform with preferential vector, recover transformed cells, propagate, monitor cells for preferential activity |
| 07/01/2003 | US6586250 Method of PCR-based gene targeting |
| 07/01/2003 | US6586248 Process for the induction of normal roots on nodes and internodes of stem segments without using hormone and/or chemical treatments in mentha species |
| 07/01/2003 | US6586247 Medium for cultivating animal embryo |
| 07/01/2003 | US6586246 Preparing porous biodegradable polymeric scaffolds for tissue engineering using effervescent salts |
| 07/01/2003 | US6586243 Producing a disease-specific immunogenic cell by isolating CD34 negative hematopoietic stem cells, incubating in culture medium with colony stimulating factor, and interleukin-4 to develop into programmable antigen presenting cells (pAPC's) |
| 07/01/2003 | US6586242 TAO protein kinases and methods of use therefor |
| 07/01/2003 | US6586240 Nucleic acid encoding a fusion protein which comprises a fluorescent domain and a binding domain obtained from a protein; use for determining location and movement |
| 07/01/2003 | US6586239 Purifying microglial cells by binding cell Fc receptor to immunoglobulin G Fc domain |
| 07/01/2003 | US6586225 Nucleotide sequence coding enzymatic polypeptide; for use in the prevention of and treatment of nervous system and autoimmune disorders; for treatment of infections, alopecia and aging |
| 07/01/2003 | US6586209 Xylanase production |
| 07/01/2003 | US6586208 Controlling the generation of poisonous protein; obtain cell, transform with vector coding poisonous protein, express vector, recover protein |
| 07/01/2003 | US6586206 Methods for making recombinant proteins using apoptosis inhibitors |
| 07/01/2003 | US6586202 Isoprenoid production |
| 07/01/2003 | US6586192 Compositions and methods for use in affecting hematopoietic stem cell populations in mammals |
| 07/01/2003 | US6586191 Isolated nucleic acids encoding mammalian galanin receptors, isolated galanin receptor proteins, vectors comprising isolated nucleic acid encoding a mammalian galanin receptor, cells comprising such vectors, antibodies directed to a |
| 07/01/2003 | US6586179 Human Eag2 |
| 07/01/2003 | US6586176 Gel microdrops in genetic analysis |
| 07/01/2003 | US6586174 Detecting CD8+ by contacting with culture of cells that contain recombinant DNA expression vector in which a reporter gene is associated with promoter sequence; measuring inhibition of reporter gene; can use in drugs for AIDS |
| 07/01/2003 | US6585982 Treatment of infertility |
| 07/01/2003 | US6585973 Solid phase adjuvant methodology is used to synthesize a hapten-protein-polysaccharide conjugate vaccines to stimulate an anti- polysaccharide antibody response in infants who are otherwise unable to respond to polysaccharide alone |
| 07/01/2003 | US6585969 Non-viable keratinocyte cell composition or lysate for promoting wound healing |
| 07/01/2003 | US6585968 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| 07/01/2003 | CA2080548C Monoclonal antibodies to hepatitis c virus |
| 07/01/2003 | CA2067469C Recombinant vaccine against marek's disease |
| 06/26/2003 | WO2003052118A2 Bgl4 beta-glucosidase and nucleic acids encoding the same |
| 06/26/2003 | WO2003052114A1 Herbal composition for improving oral hygiene, and methods of using same |
| 06/26/2003 | WO2003052110A2 Nucleic acid nematicides |
| 06/26/2003 | WO2003052102A1 Specific antibody for detecting bradeion |
| 06/26/2003 | WO2003052098A2 Method for controlled induction of somatic mutations and use thereof in proteomics |